From the Article...worth reposting one more time
...The proceeds from this equity offering will restore MSLP to financial health. $7 million will be used to pay off all debt and accounts payable. The balance sheet, henceforth, will be in pristine condition. Other uses of funds will be for international expansion and to increase the US sales force. Any residual will be for working capital purposes. Other shareholder friendly measures have been completed. During 2012 99% of all outstanding warrants have been converted leaving less than $20,000 of these derivatives on the balance sheet. Fully diluted share count for year end 2012 should be about 3 million. Mr. Pyatt has made a commitment to avoid any future dilutive derivative transactions. Finally after an earlier reverse split, the company is eligible for and has applied to be listed on the NASDAQ exchange. The company believes, and I think rightly, that the NASDAQ will give them more exposure to institutions both as potential buyers of MSLP and to pick up research coverage creating much more publicity for the company.